Living Legends in Psychopharmacology: From Evidence Base to Advances in Treatment

Overview

Expert-Led Psychopharmacology CME

Living Legends in Psychopharmacology: From Evidence Base to Advances in Treatment centers on the treatment of usual psychiatric patients with emphasis on the difficult to treat or treatment-resistant. Continuing medical education lectures will enhance your ability to choose treatments as you gain an understanding of the interface between psychiatric, neurological, and medical illness.

Legendary faculty review new antipsychotic medications and treatment augmentation, potential new uses for mood stabilizers, the neurobiologic mechanisms of depression and the role of inflammation, the importance of a therapeutic alliance when prescribing psychotropic medications, and more. With this online CME program, you’ll explore current evidence-based and emerging treatments for:

• Schizophrenia and bipolar disorder
• Bipolar and treatment-resistant depression
• TMS and ECT
• Anxiety spectrum and sleep disorders
• PTSD
• Alcohol and substance abuse disorders
• Women's mental health issues
• Child, adolescent, and geriatric psychopharmacology

Topics / Speakers

Lessons Learned from the DNA of Patients with Psychiatric Disorders - Daniel Weinberger, MD

Neurology and Psychiatry Interface - Martin Samuels, MD, DSc (hon)

The Interface of Medical and Psychiatric Disorders – Focus on Cancer and Heart Disease - Charles Nemeroff, MD, PhD

Tackling Unsolved Problems in the Pharmacological Treatment of Schizophrenia – Cognitive Impairment, Negative Symptoms, and Partial Treatment Response - Philip Harvey, PhD

Panel Discussion - Philip Harvey, PhD, Charles Nemeroff, MD, PhD, Martin Samuels, MD, DSc (hon), and Daniel Weinberger, MD

Pharmacological Treatment of Bipolar Disorder - Ross Baldessarini, MD, DSc (hon)

Anxiety – Treat the Symptom or Treat the Disorder When First Line Therapies Fail - Stephen M. Stahl, MD, PhD, DSc (hon)

Neurobiology and Treatment of Post-traumatic Stress Disorder - Charles Nemeroff, MD, PhD

Panel Discussion - Ross Baldessarini, MD, DSc (hon) and Charles Nemeroff, MD, PhD

Psychopharmacologic Treatment of Sleep Disorders - Sogol Javaheri, MD

Treatment Resistant Depression - Stephen M. Stahl, MD, PhD, DSc (hon)

Psychedelics and Potential Drugs of Abuse as Antidepressants - Alan F. Schatzberg, MD

Pharmacotherapy of Substance Use Disorders - Roger D. Weiss, MD

Panel Discussion - Barbara Coffey, MD, MS, Sogol Javaheri, MD, Alan F. Schatzberg, MD, Stephen M. Stahl, MD, PhD, DSc (hon), and Roger D. Weiss, MD

Child and Adolescent Psychopharmacology – Current Treatment for Best Practices - Barbara J. Coffey, MD, MS

Psychopharmacology Across the Reproductive Lifespan – From Menarche to Menopause - Ariadna Forray, MD

Geriatric Psychopharmacology - Elizabeth Crocco, MD

Panel Discussion - Barbara J. Coffey, MD, MS, Elizabeth Crocco, MD, and Ariadna Forray, MD

Faculty

Accreditation

ABMS/ACGME Competencies

This course is designed to meet the following American Board of Medical Specialties (ABMS)/Accreditation Council for Graduate Medical Educational (ACGME) competencies: Medical knowledge.

Accreditation

The University of Miami Leonard M. Miller School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

Physician Credit: The University of Miami Leonard M. Miller School of Medicine designates this enduring material for a maximum of 13.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

European Accreditation: Through an agreement between the American Medical Association and the European Union of Medical Specialists, physicians may convert AMA PRA Category 1 Credit™ to an equivalent number of European CME Credits^® (ECMECs^®). Information on the process of converting AMA PRA Category 1 Credits™ to ECMECs^® can be found at: www.eaccme.eu.

Physician Assistants: The National Commission on Certification of Physician Assistants (NCCPA) states that AMA PRA Category 1 Credits™ are acceptable for continuing medical education requirements for recertification. We would also suggest that learners check with their state licensing board to ensure they accept reciprocity with AMA PRA Category 1 Credit™ for re-licensure.

Nursing: Oakstone Publishing is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
Contact Hours: 13.

Date of Original Release: June 1, 2023
Termination Date: May 31, 2026
Estimated Time to Complete: 13.00 hours

CME credit is awarded upon successful completion of a course evaluation and post-test.

Learning Objectives

At the completion of this course, you should be able to:

• Describe lessons learned from genomic sequencing of patients with psychiatric illnesses
• Identify unsolved problems regarding the pharmacologic treatment of schizophrenia and learning more effective treatments
• Describe emerging theories and treatments of bipolar disorder, difficult-to-treat depression, bipolar depression, and anxiety disorder
• Outline the perils and possibilities of psychedelics and ketamine
• Recognize when to utilize ECT and TMS for treatment-resistant depression
• Illustrate emerging treatments for PTSD
• Review sleep disorders commonly comorbid with psychiatric illness, and appropriate use of medications and treatment
• Review interface of medicine and psychiatry with a focus on cancer, cardiovascular disease
• Review the interface of neurology and psychiatry with an emphasis on functional neurological disease, hysteria, movement disorders, pain, OCD and others
• Summarize the use of genetic tests, serum level measurements, and drug combinations in treatment-resistant depression
• Identify the current role of pharmacotherapy in the treatment of substance use disorders including alcohol, opioids, and cannabis
• Review the role of pharmacotherapy in the treatment of psychiatric disorders throughout women’s reproductive lifespan, with a focus on the premenstrual, prenatal, postpartum, and perimenopausal periods
• Examine the latest advances and problems associated with treatment approaches in the child, adolescent, and geriatric populations

Intended Audience

Practicing clinicians in the field of psychopharmacology drawn from the following disciplines: psychiatry, medicine, nursing, nurse practitioners, and psychology.

Disclosure and Conflict of Interest Mitigation

The University of Miami Leonard M. Miller School of Medicine has assessed conflict of interest with its faculty, authors, editors, and any individuals who were in a position to control the content of this CME activity. Any identified relevant conflicts of interest have been mitigated. The University of Miami Leonard M. Miller School of Medicine planners, content reviewers, and editorial staff disclose no relationships with ineligible entities.

All the relevant financial relationships for these individuals have been mitigated.

Quick Facts

Provider: The University of Miami Leonard M. Miller School of Medicine

Course Directors:
Barbara J. Coffey, MD, MS
Professor and Chairman
Department of Psychiatry and Behavioral Sciences
Chief, Division of Child and Adolescent Psychiatry
University of Miami Miller School of Medicine

Charles Nemeroff, MD, PhD
Matthew P. Nemeroff Professor and Chair
Department of Psychiatry and Behavioral Sciences
Mulva Clinic for the Neurosciences
Director, Institute of Early Life Adversity Research
Dell Medical School
The University of Texas at Austin

Credits: Earn a maximum of 13.00 AMA PRA Category 1 Credits™